Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Actelion HQ Switzerland

Actelion claims first approval for PAH therapy Uptravi

Gains US approval from the FDA for its key pipeline drug

- PMLiVE

Lars Dreiøe joins Sobi in senior quality and compliance role

Moves to the Swedish rare diseases company from Denmark's ALK

- PMLiVE

M3 Europe appoints Helen Parfitt and Grant Irwin

Healthcare technology company boosts its senior team

- PMLiVE

Shkreli fallout claims Turing jobs and KaloBios’ listing

Both firms continue to suffer with job cuts and de-listing from the Nasdaq

- PMLiVE

Boehringer plans €500m biopharma expansion in Austria

New production facility in Vienna will create 400 jobs when it comes online in 2021

- PMLiVE

Nucala price far too high for US market, says ICER

Concludes GlaxoSmithKline's new severe asthma therapy is not value for money

- PMLiVE

Isis renamed Ionis to sidestep militant association

Says the move should avoid any 'distraction' to its business

- PMLiVE

Update: Shkreli resigns as Turing CEO, ousted from KaloBios

Shares in KaloBios had been hit hard when news of his arrest broke

- PMLiVE

Keytruda bounces back in rivalry with Opdivo

First drug in its class to secure FDA approval as a first-line therapy for malignant melanoma

- PMLiVE

Bayer forms JV with gene editing firm CRISPR

$300m investment to find new therapies for blood disorders, blindness and congenital heart disease

- PMLiVE

Digital health: Breaking barriers in Health by Debashis Bhattacharya and Kamlesh Sheth

Co-founding directors of Aegleio, Kamlesh Sheth and Debashis Bhattacharya, urge us to welcome digital health.

Say Communications

EU flag

Nine positive opinions for new drugs at CHMP meeting

Tagrisso, Zurampic and Portrazza among the latest recommendations

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links